ARCHIVES

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

Brenner To Leave Breast Cancer Action

September 17, 2010

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

Tobacco Company Liggett Gave $3.6 Million To Henschke For CT Screening Research.

March 28, 2008

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977